Clinical Trial Update: Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether amiodarone can prevent atrial fibrillation after minimally invasive esophagectomy in patients with esophageal can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Esophageal Cancer

Drugs mentioned

• Amiodarone (amiodarone)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Atrial Fibrillation, Esophageal Carcinoma | Phase 2 | Status: RECRUITING